Skip to main content
×
Subscribe
Login
Main navigation
Show — Main navigation
Hide — Main navigation
Home
Journal
Current Issue
Archive
Subscribe
Author Guidelines
Editorial Board
Partners
Editorial Information
Departments
Aesthetics Corner
Allergen Focus
Board Review
Business Insider
Clinical Tips
DermDx
The Dermatopathologist
Hair & Scalp
Surgical Insights
Online Resources
Clinical Update
Dermatology Advances
Expert Insights in AD
FDA Alerts
News
Podcasts
Polls
Q&A
Quizzes
Videos
Topics
Acne
Aesthetics
Cutaneous & COVID
Eczema
General Dermatology
Hidradenitis Suppurativa
Infectious Dermatology
Pediatric Dermatology
Practice Advances
Professional Development
Psoriasis
Psoriatic Arthritis
Rosacea
Skin Cancer
Excellence Forums
Acne
Atopic Dermatitis
Psoriasis
Meetings
Winter Clinical
Maui Derm
Skin Cancer Symposium
Symposium for Inflammatory Skin Disease
Contact
Topic Centers
Acne
Actinic Keratosis
Aesthetics
Eczema
Hidradenitis Suppurativa
Infectious Dermatology
Pediatric Dermatology
Psoriasis
Psoriatic Arthritis
Rosacea
Skin Cancer
FDA Alerts
FDA Approves New Treatment for Facial and Truncal Acne
The FDA recently approved a new topical retinoid for the treatment of acne on both the face and the trunk.
FDA Approves Expanded Indication of Topical Acne Treatment
The FDA approved the expanded indication of topical dapsone 7.5% gel for the treatment of acne vulgaris in patients aged 9 to 11 years.
FDA Approves Therapy for Oral Ulcers Associated with Rare Disease
The FDA approved a new treatment option for patients with oral ulcers associated with Behçet disease.
FDA Approves New Option for Chronic Rhinosinusitis With Nasal Polyps
The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.
FDA Approves New Psoriasis Treatment for Adolescents
The FDA approved a new foam treatment for adolescents with plaque psoriasis on the scalp and body.
FDA Approves Enbrel Biosimilar
The FDA has approved a second biosimilar to etanercept for the treatment of various autoimmune conditions.
FDA Approves Topical Therapy for Psoriasis
The FDA has approved a new topical therapy for the treatment of plaque psoriasis in adult patients.
FDA Approves New Therapy for Psoriasis
The FDA approved a new biologic for the treatment of moderate to severe plaque psoriasis.
FDA Approves Biologic for Adolescents with Eczema
The FDA approved dupiliumab for the treatment of moderate to severe atopic dermatitis in adolescents.
FDA Approves New Biosimilar
The FDA has approved a new biosimilar for patients with various autoimmune diseases, including psoriasis and psoriatic arthritis.
Pagination
Previous page
‹‹
Page 2
Next page
››
Stay in the know.
The Dermatologist Newsletter
Back to Top